Incidencia de insuficiencia renal terminal por nefropatía diabética

If we analyze what has happened in Europe since the Declaration of Sant Vincent, then, based on the numbers in the registry of the European Renal Association-European Dialysis and Transplant Association, we would probably have to conclude that, in relation to diabetic rephropathy (ND), the objectives proposed have not been achieved. However, the way this problem has been focused requires some reflections. We do not know what exactly the increase in new cases of terminal renal insufficiency due to ND means. On the other hand, it cannot be denied that the quality of health care related to the management of these patients has improved. Diagnosis is achieved earlier, new drugs have been introduced for more effective treatment of hyperglycemia and hypertension and the idea of obtaining regulated therapeutic objectives with proven efficacy on evolution has now become generalized among the professionals treating patients with ND. In order to know whether advances in the prevention and treatment of ND have, indeed, been achieved, it is undoubtedly essential to periodically repeat studies which have analyzed markers of healthcare quality which may be influenced by our medical practice. The efforts made could probably have been greater and we should not be satisfied with the reported. results On the other hand, neither can we be pessimistic and think that nothing has changed since the Declaration of Sant Vincent.